Anavex Life Sciences Corp (AVXL)

[Investor2014]

By that definition a lot of ordinary medicine now becomes precision medicine.

I posted the definitions from the various regulatory agencies and it seems to me people are massaging those consistent definitions in an attempt to fit what Anavex are doing.

Yet Anavex themselves have appropriately been changing the wording of their approach.

Simply optimising/titrating dose does not turn a treatment into precision medicine.

Why is it so important to people to that Anavex A2-73 must be precision medicine, when it turns out it really isn’t?

A2-73 may still be successful and treat most patients rather than just a select subgroup or groups based on patient characteristics.